ATE452655T1 - Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung - Google Patents

Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung

Info

Publication number
ATE452655T1
ATE452655T1 AT01114110T AT01114110T ATE452655T1 AT E452655 T1 ATE452655 T1 AT E452655T1 AT 01114110 T AT01114110 T AT 01114110T AT 01114110 T AT01114110 T AT 01114110T AT E452655 T1 ATE452655 T1 AT E452655T1
Authority
AT
Austria
Prior art keywords
polynucleotides
diagnostic imaging
polynucleotide
imaging
spiegelmer
Prior art date
Application number
AT01114110T
Other languages
English (en)
Inventor
Sven Klussmann
Britta Wlotzka
Original Assignee
Noxxon Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noxxon Pharma Ag filed Critical Noxxon Pharma Ag
Application granted granted Critical
Publication of ATE452655T1 publication Critical patent/ATE452655T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
AT01114110T 2001-06-10 2001-06-10 Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung ATE452655T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01114110A EP1264603B8 (de) 2001-06-10 2001-06-10 Verwendung von L-Polynukleotiden zur diagnostischen Bilderzeugung

Publications (1)

Publication Number Publication Date
ATE452655T1 true ATE452655T1 (de) 2010-01-15

Family

ID=8177688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01114110T ATE452655T1 (de) 2001-06-10 2001-06-10 Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung

Country Status (6)

Country Link
EP (1) EP1264603B8 (de)
AT (1) ATE452655T1 (de)
AU (1) AU2002331313A1 (de)
DE (1) DE60140863D1 (de)
DK (1) DK1264603T3 (de)
WO (1) WO2002100442A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1605978B1 (de) * 2003-03-07 2010-09-01 Alnylam Pharmaceuticals Inc. Therapeutische zusammensetzungen
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
WO2007070682A2 (en) 2005-12-15 2007-06-21 Massachusetts Institute Of Technology System for screening particles
WO2007133807A2 (en) 2006-05-15 2007-11-22 Massachusetts Institute Of Technology Polymers for functional particles
US9381477B2 (en) 2006-06-23 2016-07-05 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
US9217129B2 (en) 2007-02-09 2015-12-22 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
JP2010523595A (ja) 2007-04-04 2010-07-15 マサチューセッツ インスティテュート オブ テクノロジー ポリ（アミノ酸）ターゲッティング部分
US10736848B2 (en) 2007-10-12 2020-08-11 Massachusetts Institute Of Technology Vaccine nanotechnology
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8277812B2 (en) 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
AU2011258156B2 (en) 2010-05-26 2016-11-24 Selecta Biosciences, Inc. Multivalent synthetic nanocarrier vaccines
DE102010056610A1 (de) * 2010-12-31 2012-07-05 Volker A. Erdmann Pharmazeutische Zusammensetzung enthaltend L-DNA
CA2824073A1 (en) * 2011-01-10 2012-07-19 Noxxon Pharma Ag Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same
CN112587658A (zh) 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
US10548985B2 (en) 2014-01-10 2020-02-04 Birdie Biopharmaceuticals, Inc. Compounds and compositions for treating EGFR expressing tumors
DK3166976T3 (da) 2014-07-09 2022-04-11 Birdie Biopharmaceuticals Inc Anti-pd-l1-kombinationer til behandling af tumorer
CN105233291A (zh) 2014-07-09 2016-01-13 博笛生物科技有限公司 用于治疗癌症的联合治疗组合物和联合治疗方法
CN112587672A (zh) 2014-09-01 2021-04-02 博笛生物科技有限公司 用于***的抗-pd-l1结合物
CN107613980A (zh) 2015-05-31 2018-01-19 源生公司 用于免疫疗法的组合组合物
CN110559456B (zh) * 2019-10-28 2021-07-23 中国科学院武汉物理与数学研究所 一种19f-穴番纳米乳的磁共振成像显影剂的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6402594A (en) * 1993-03-10 1994-09-26 Wellcome Foundation Limited, The Tumor targeting with l-enantiomeric oligonucleotide conjugates of immunoreagents and of chelated radionuclides
WO1996034879A1 (en) * 1995-05-03 1996-11-07 Whitehead Institute For Biomedical Research Identification of enantiomeric ligands
AU743469C (en) * 1996-08-30 2004-02-12 Rolf Bald Mirror-symmetrical selection and evolution of nucleic acids

Also Published As

Publication number Publication date
WO2002100442A2 (en) 2002-12-19
AU2002331313A1 (en) 2002-12-23
EP1264603B8 (de) 2010-03-03
EP1264603A1 (de) 2002-12-11
WO2002100442A3 (en) 2003-04-10
EP1264603B1 (de) 2009-12-23
DE60140863D1 (de) 2010-02-04
DK1264603T3 (da) 2010-04-26

Similar Documents

Publication Publication Date Title
ATE452655T1 (de) Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung
DE60227718D1 (de) Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
DE60222644D1 (de) Prozess zur herstellung von transparenten formteilen
DE60206996D1 (de) Verfahren zur Herstellung von 3-l-Menthoxypropan-1,2-diol
DE60307710D1 (de) Verfahren zur Herstellung von Eisenoxiden
DE60211106D1 (de) Zusammensetzung zur Oxidationsfärbung von Keratinfasern
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE60208738D1 (de) Verfahren zur Herstellung von Chlorfluorpolyoxyalkylenolen
DE60237639D1 (de) Methode zur bestimmung der biologischen aktivität von difibrotid
DE60225953D1 (de) Verfahren zur Herstellung von Polyamid
DE60239842D1 (de) Verfahren zur Herstellung von 10,11-dihydro-10-oxo-5h-dibenzoÄb,fÜazepin-5-carboxamid
DE10290269T1 (de) Verfahren zur Herstellung von Zyklischem Formal
ATE416756T1 (de) Methoden zur verwendung von lamellaren körpern für therapeutische zwecke
DE50209948D1 (de) Verwendung von Scopinester Derivaten zur Herstellung von Arzneimitteln
ATE361755T1 (de) Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungen
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DE60239085D1 (de) Prozess zur Herstellung von E-Caprolactam
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
DE60222081D1 (de) Verfahren zur Herstellung von linearen Organopolysiloxanen
DE60108105D1 (de) Verfahren zur Herstellung von 5-substituierten Isobenzofuranen
DE602004002692D1 (de) Verfahren zur Herstellung von Topiramate
DE60208365D1 (de) Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties